Supremin syrup 4mg/5 ml 200ml — Made in Poland by Teva — Free Delivery

Product description

Supremin is an antitussive medicinal product indicated for use in acute dry cough. Product for use in adults and children from 2 years of age. The active substance (butamirate citrate) contained in the preparation is an antitussive substance. It relieves cough by centrally inhibiting the unproductive (dry, tiring) cough reflex, reducing its frequency and intensity. Butamirate citrate acts peripherally by slightly dilating the bronchi by a cholinolytic mechanism which may facilitate breathing.

Indications

A dry, sharp cough.

Composition

5 ml of syrup (1 teaspoon) contains:

• active ingredient: butamirate citrate 4 mg,
• excipients: methyl parahydroxybenzoate, benzoic acid, anhydrous citric acid, sodium citrate, liquid maltitol, aspartame, caramel-orange flavor (E 34493), purified water.

Action

Antitussive, relaxing the bronchial muscles, facilitating breathing.

Dosage

Children from 2 to 6 years of age: 4 mg (1 measuring spoon) 3 times a day

Children from 6 to 12 years of age: 8 mg (2 measuring spoons) 3 times a day

Children over 12 years of age: 12 mg (3 measuring spoons) 3 times a day

Adults: 12 mg (3 measuring spoons) 4 times a day.

The product should be used before meals.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed

Phenylketonuria.

Storage

Store below 25 ° C.

Side effects

Uncommon (> 1/1000 to <1/100):

• skin and subcutaneous tissue disorders: rash,
• gastrointestinal disorders: nausea, diarrhea,
• nervous system disorders: dizziness.

These symptoms usually disappear with treatment and rarely require dose reduction. If the allergic reactions or gastrointestinal disturbances described above do not resolve after a dose reduction, treatment should be discontinued

Interactions

Unknown.

Warnings and Precautions

The preparation should not be used in patients with symptoms of severe respiratory depression.

The product should not be used for more than a few days.

Due to the content of benzoic acid and methyl parahydroxybenzoate, the medicinal product may cause allergic reactions (possible delayed reactions).

The product contains aspartame, a source of phenylalanine. May be harmful for patients with phenylketonuria. 5 ml of syrup contains 12.5 mg of aspartame.

The product contains liquid maltitol, therefore it should not be used in patients with rare hereditary fructose intolerance. The preparation may have a mild laxative effect.

Caloric value of 2.3 kcal / g of maltitol.

Butamirate has a high therapeutic index and therefore symptoms of overdose occur only in cases of large amounts of the preparation. Symptoms of butamirate overdose are somnolence, vomiting, abdominal pain, diarrhea, ataxia, agitation and low blood pressure.

In case of overdose, gastric lavage should be performed, activated charcoal and laxatives should be administered.

Effects on fertility, pregnancy and lactation

The medicinal product should not be used in women during the first trimester of pregnancy. During the second and third trimesters of pregnancy and during breastfeeding, the product may only be used when needed.

Effects on the ability to drive and use machines

Due to the possibility of side effects, in rare cases the ability to drive and use machines may be impaired.